United European Gastroenterol J. 2017 Aug;5(5):658-667. doi: 10.1177/2050640616680550. Epub 2016 Nov 16.
Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.
United European gastroenterology journal
Berrie Meijer, Melek Simsek, Hans Blokzijl, Robert A de Man, Minneke J Coenraad, Gerard Dijkstra, Carin Mj van Nieuwkerk, Chris Jj Mulder, Nanne Kh de Boer
Affiliations
Affiliations
- Department of Gastroenterology and Hepatology, VU University Medical Center Amsterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
PMID: 28815029
PMCID: PMC5548351 DOI: 10.1177/2050640616680550
Abstract
BACKGROUND: Nodular regenerative hyperplasia is an uncommon liver condition associated with several autoimmune disorders and drugs. The clinical symptoms of nodular regenerative hyperplasia vary from asymptomatic to severe complications of portal hypertension (nodular regenerative hyperplasia-syndrome).
OBJECTIVE: The purpose of this study was to identify the prognosis and optimal management, as well as the role of liver transplantation, in nodular regenerative hyperplasia.
METHODS: The pathology databases of all three Dutch liver transplant units were retrospectively scrutinised for explanted livers diagnosed with nodular regenerative hyperplasia or without clear diagnosis. Pre- and post-transplantation clinical, biochemical, radiological and histological information was obtained from electronic and paper records.
RESULTS: In total, 1886 patients received a liver transplant. In 255 patients, nodular regenerative hyperplasia could not be excluded. After detailed chart review, the native livers of 11 patients (0.6%) (82% male, median age: 44 years) displayed nodular regenerative hyperplasia. Seven patients (64%) had underlying disorders or drug exposure which possibly caused nodular regenerative hyperplasia. Laboratory and imaging abnormalities were present in all patients but did not contribute to the diagnosis of nodular regenerative hyperplasia. Five-year survival was 73% (median follow-up: four years, range: 2-248 months).
CONCLUSION: Nodular regenerative hyperplasia is a rare finding in patients, predominantly young males, transplanted for end-stage liver disease with unknown aetiology. Nonetheless, liver transplantation may have an important role in end-stage nodular regenerative hyperplasia-syndrome.
Keywords: Liver transplantation; drug-induced liver injury; hepatotoxicity; nodular regenerative hyperplasia; portal hypertension
References
- Am Surg. 2000 Nov;66(11):1067-70 - PubMed
- Eur J Gastroenterol Hepatol. 2008 Jan;20(1):68-72 - PubMed
- Intern Med. 2015;54(4):383-7 - PubMed
- Gut. 2005 Jul;54(7):1021-3 - PubMed
- Hepatology. 1990 May;11(5):787-97 - PubMed
- Liver Int. 2016 Jul;36(7):1059-66 - PubMed
- Am J Gastroenterol. 1989 May;84(5):548-51 - PubMed
- Am J Gastroenterol. 2007 Jul;102(7):1518-27 - PubMed
- Dig Liver Dis. 2008 Feb;40(2):108-13 - PubMed
- J Pediatr Gastroenterol Nutr. 2005 Aug;41(2):251-5 - PubMed
- Hepatogastroenterology. 2001 Sep-Oct;48(41):1425-9 - PubMed
- Chest. 2015 Oct;148(4):1019-1026 - PubMed
- Transplantation. 2013 Dec 15;96(11):e79-81 - PubMed
- Liver Transpl. 2008 Aug;14(8):1194-8 - PubMed
- World J Gastroenterol. 2011 Mar 21;17(11):1400-9 - PubMed
- Nat Clin Pract Gastroenterol Hepatol. 2007 Dec;4(12):686-94 - PubMed
- J Hepatol. 1991 Jan;12(1):94-9 - PubMed
- Dig Liver Dis. 2011 Feb;43(2):110-5 - PubMed
- Gastroenterology. 2003 Aug;125(2):298-303 - PubMed
- Dig Liver Dis. 2011 Dec;43(12):929-34 - PubMed
- Gut. 1990 Jun;31(6):725-7 - PubMed
- Scand J Gastroenterol. 2008;43(5):604-8 - PubMed
- Hepatology. 1994 Jul;20(1 Pt 1):88-94 - PubMed
- Liver Transpl. 2007 Nov;13(11):1552-6 - PubMed
- Medicine (Baltimore). 1980 Sep;59(5):367-79 - PubMed
- Inflamm Bowel Dis. 2016 Sep;22(9):2112-20 - PubMed
- Liver Transpl. 2005 Jun;11(6):627-34; discussion 610-1 - PubMed
- Transplant Proc. 2011 Sep;43(7):2814-6 - PubMed
- Liver. 1989 Oct;9(5):253-65 - PubMed
- Am J Pathol. 1959 Sep-Oct;35:943-53 - PubMed
- Hepatogastroenterology. 1998 Sep-Oct;45(23):1787-94 - PubMed
- Hepatology. 1995 Sep;22(3):983-93 - PubMed
- World J Hepatol. 2014 Jan 27;6(1):55-63 - PubMed
- Hepatology. 2006 Jul;44(1):7-14 - PubMed
- Scand J Gastroenterol. 2001 Apr;36(4):417-22 - PubMed
- Transpl Int. 1994 Jul;7(4):309-13 - PubMed
- PLoS One. 2015 Jun 08;10(6):e0120299 - PubMed
- Gut. 2007 Oct;56(10):1404-9 - PubMed
- Am J Transplant. 2003 Dec;3(12):1604-7 - PubMed
- Inflamm Bowel Dis. 2007 Sep;13(9):1106-14 - PubMed
Publication Types